Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
International Journal of Medicinal Mushrooms|June 19, 2014
Antimicrobial effect of the Lingzhi or Reishi medicinal mushroom, Ganoderma lucidum (higher Basidiomycetes) and its main compoundsMahdi Vazirian, Mohammad Ali Faramarzi, Seyed Esmaeil Sadat Ebrahimi, et al.
RSC Advances|February 2, 2026
Design, synthesis, in vitro, and in silico studies on promising α-glucosidase inhibitors based on a quinazolinone-thiophene scaffoldParsa Baghershahi, Navid Dastyafteh, Mohammad Halimi, et al.
Bioorganic Chemistry|January 10, 2026
Design, synthesis, and antidiabetic evaluation of triazolopyrimidine thioacetamides as potent and selective α-glucosidase inhibitorsFariba Peytam, Maryam Norouzbahari, Bahareh Bayati, et al.
Bioorganic Chemistry|August 25, 2019
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studiesMohammad Sadegh Asgari, Maryam Mohammadi-Khanaposhtani, Mitra Kiani, et al.
Bioorganic Chemistry|October 27, 2018
Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking studyMina Saeedi, Maryam Mohammadi-Khanaposhtani, Parvaneh Pourrabia, et al.
Bioorganic Chemistry|July 3, 2024
α-Glucosidase inhibition assay of galbanic acid and it amide derivatives: New excellent semi-synthetic α-glucosidase inhibitorsMaryam Mohammadi-Khanaposhtani, Mohammad Hosein Sayahi, Rozita Yazzaf, et al.
Scientific Reports|May 20, 2025
1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitorsElham Safaie, Mohammad Hosein Sayahi, Navid Dastyafteh, et al.
Pageof 27